Gradual rise in Japan's generic drug use

29 March 2009

Although in Japan the dispensing rate of generic drugs on a prescription basis had risen slightly from 40.2% in January to 41.8% in July 2008,  this has gradually increased from 41.7% in August to 43.9% in December,  according to the results of a usage status survey conducted by the  Ministry of Health, Labor and Welfare, which was submitted to the  Central Social Insurance Medical Council, the Chuikyo.

The survey was conducted among 944 health insurance pharmacies, 733  clinics, 326 hospitals, 431 hospital physicians and 1,717 patients.

In the insurance pharmacy survey of December 2008, 44% of pharmacies  said they had dispensed at least one generic drug in all issued  prescriptions, while 56% had not. 65.6% of these pharmacies accepted a  prescription which contained no signature in the column stating "Do not  change to generic drugs." However, among them, 9.1% answered that they  had not substituted because there was no copy version available in  accordance with the specifications in original drugs. Meanwhile, 34.4%  of the pharmacies accepted a prescription which contained a physician's  signature in the above column.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight